Indaptus Therapeutics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$19.8 | -$15.4 | -$16.4 | -$14.9 | -$7.7 |
| Net income | -$20.8 | -$15.0 | -$15.4 | -$14.3 | -$7.7 |
| Cash Flow Statement | |||||
| Free cash flow | — | — | — | — | -$11.3 |
Shares outstanding 113.2M
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.